Addabbo, F;
Baglioni, V;
Schrag, A;
Schwarz, MJ;
Dietrich, A;
Hoekstra, PJ;
Martino, D;
... Emtics Collaborative Group; + view all
(2020)
Anti‐dopamine D2 receptor antibodies in chronic tic disorders.
Developmental Medicine & Child Neurology
, 62
(10)
pp. 1205-1212.
10.1111/dmcn.14613.
Preview |
Text
Schrag_anti-D2R paper _ revised Oct 3 2019.pdf - Accepted Version Download (514kB) | Preview |
Abstract
AIM: To investigate the association between circulating anti-dopamine D2 receptor (D2R) autoantibodies and the exacerbation of tics in children with chronic tic disorders (CTDs). METHOD: One hundred and thirty-seven children with CTDs (108 males, 29 females; mean age [SD] 10y 0mo [2y 7mo], range 4-16y) were recruited over 18 months. Patients were assessed at baseline, at tic exacerbation, and at 2 months after exacerbation. Serum anti-D2R antibodies were evaluated using a cell-based assay and blinded immunofluorescence microscopy scoring was performed by two raters. The association between visit type and presence of anti-D2R antibodies was measured with McNemar's test and repeated-measure logistic regression models, adjusting for potential demographic and clinical confounders. RESULTS: At exacerbation, 11 (8%) participants became anti-D2R-positive ('early peri-exacerbation seroconverters'), and nine (6.6%) became anti-D2R-positive at post-exacerbation ('late peri-exacerbation seroconverters'). The anti-D2R antibodies were significantly associated with exacerbations when compared to baseline (McNemar's odds ratio=11, p=0.003) and conditional logistic regression confirmed this association (Z=3.49, p<0.001) after adjustment for demographic and clinical data and use of psychotropic drugs. INTERPRETATION: There is a potential association between immune mechanisms and the severity course of tics in adolescents with CTDs.
Archive Staff Only
 |
View Item |
